AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin.
Badmann S, Mayr D, Schmoeckel E, Hester A, Buschmann C, Beyer S, Kolben T, Kraus F, Chelariu-Raicu A, Burges A, Mahner S, Jeschke U, Trillsch F, Czogalla B.
Badmann S, et al. Among authors: mahner s.
Sci Rep. 2022 Feb 3;12(1):1862. doi: 10.1038/s41598-022-05785-9.
Sci Rep. 2022.
PMID: 35115586
Free PMC article.